Dabrafenib
Dabrafenib is a compound used as a serine/threonine-protein kinase B-Raf inhibitor for oncology research. It competitively inhibits V600E BRAF gene mutations which are characteristic in melanoma cancers. Inhibition of B-Raf proteins, by dabrafenib, interrupts mitogen-activated protein kinase/extracellular signal regulated kinase (MAPK/ERK) pathways, which regulate cell growth.This action halts cell proliferative activity and engages apoptosis.Product SpecificationsDabrafenibFormula: C23H20F3N5O2S2MW: 519.56 g/mol
Product Specifications
CAS Number
1195765-45-7
Molecular Weight
519.56 g/mol
Identity
D-210
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
C7864 96 Tests
Cytoplasmic dynein 1 intermediate chain 1 (DYNC1I1) Rat ELISA Kit
Sign In for Pricing
View Details bs-12497R-BF647 100 µL
Apolipoprotein CII/APOC2 Polyclonal Antibody, AbBy Fluor™ 647 Conjugated
Sign In for Pricing
View Details MBS9909803-01 48 Well
Hamster Period Circadian Protein Homolog 1 (PER1) ELISA Kit
Sign In for Pricing
View Details